REV UP “KILLER CELLS” TO TREAT ECZEMA?
A new drug strategy aimed at revving up the immune system and boosting natural killer (NK) cells effectively treated eczema in mice
www.EczemaTreatmentReport.com
REV UP “KILLER CELLS” TO TREAT ECZEMA?
A new drug strategy aimed at revving up the immune system and boosting natural killer (NK) cells effectively treated eczema in mice
http://www.koreabiomed.com/news/articleView.html?idxno=7548
JW Shinyak launches new hand eczema treatment for patients who do not respond to topical steroid therapy
Unitok, capsule, alitretinoin
https://www.dermatologytimes.com/atopic-dermatitis/dont-use-vinegar-treat-atopic-dermatitis
Don’t use vinegar to treat atopic dermatitis
Man who struggled with eczema on his face for years is treating the condition by drying out his skin
Man who struggled with eczema on his face for years is treating the condition by drying out his skin
MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II
https://www.fiercebiotech.com/research/uk-team-sheds-light-how-anaptysbio-s-anti-il-33-eczema-drug-tamps-down-inflammation
Research
U.K. team sheds light on how AnaptysBio’s anti-IL-33 eczema drug tamps down inflammation
https://www.dailymail.co.uk/health/article-7605453/Pioneering-eczema-jab-improves-skin-patients-month.html
Just one dose of ‘hugely exciting’ eczema jab ‘improves the skin of patients within a month’
Oxford University scientists found the jab improved the skin of 12 patients
Charities said the results of the study on etokimab were ‘hugely exciting’
Researchers are now planning to trial the treatment on 300 eczema sufferers
https://www.imm.ox.ac.uk/about/news/promising-therapy-for-common-form-of-eczema-identified-in-early-stage-trial
https://medicalxpress.com/news/2019-10-therapy-common-eczema-early-stage-trial.html
Promising therapy for common form of eczema identified in early-stage trial
A therapy that targets the immune system showed promise for treating atopic dermatitis – the most common form of eczema – in a small proof-of-concept trial, led by scientists from the MRC HIU.
https://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_positive_top_line_results_from_phase_3_study_of_investigational_oral_jak1_candidate_abrocitinib_pf_04965842_in_patients_aged_12_and_older_with_moderate_to_severe_atopic_dermatitis
https://www.bloomberg.com/press-releases/2019-09-27/pfizer-announces-positive-top-line-results-from-second-pivotal-phase-3-study-of-investigational-oral-jak1-candidate
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib, in Patients with Moderate to Severe Atopic Dermatitis
https://medicalxpress.com/news/2019-08-scientists-skin-microbiome-health-index.html
Scientists use skin’s microbiome to develop health index for children with eczema
https://nationaleczema.org/nemolizumab-lebrikizumab/
Two new atopic dermatitis biologics show promising results in phase IIb clinical trials
Galderma’s nemolizumab and Dermira’s lebrikizumab are two new biologics for atopic dermatitis that are working their way toward FDA approval.
https://www.sciencealert.com/scientists-think-they-know-what-happens-in-the-skin-when-you-have-eczema
Scientists Think They Finally Know What Happens in The Skin When You Have Eczema